高附加光度与中附加光度及单光接触镜对儿童近视进展的影响:BLINK随机临床试验
BLINK双盲随机临床试验纳入294名7-11岁近视儿童,随机佩戴高附加光度(+2.50 D)、中附加光度(+1.50 D)或多焦软镜或单光接触镜。3年随访显示,高附加光度组近视进展(-0.60 D)显著低于中附加光度组(-0.89 D)和单光组(-1.05 D),眼轴增长也显著减少,但差异的临床重要性仍需进一步研究。
要点
- 高附加光度多焦软镜可显著减缓儿童近视进展和眼轴增长。
- 高附加光度组3年近视进展比单光组少0.46 D,比中附加光度组少0.30 D。
- 中附加光度与单光组近视进展差异无统计学意义。
核心结论
- 高附加光度多焦软镜治疗显著降低了3年近视进展速率,优于中附加光度和单光接触镜。
- 观察到的差异的临床重要性尚需进一步研究。
研究设计与样本
- 双盲随机临床试验,在俄亥俄州哥伦布和德克萨斯州休斯顿的两个视光学院进行。
- 共纳入294名7至11岁、球镜度-0.75 D至-5.00 D、散光小于1.00 D的儿童,随机分为高附加光度组(n=98)、中附加光度组(n=98)和单光组(n=98)。
- 主要结局为3年睫状肌麻痹验光等效球镜度变化,取10次自动验光读数的平均值。
主要发现
- 调整后3年近视进展:高附加光度组-0.60 D,中附加光度组-0.89 D,单光组-1.05 D。
- 高附加光度 vs 单光组进展差异0.46 D(95% CI,0.29-0.63);高附加光度 vs 中附加光度组0.30 D(95% CI,0.13-0.47);中附加光度 vs 单光组0.16 D(95% CI,-0.01 to 0.33)。
- 调整后平均眼轴增长:高附加光度组0.42 mm,中附加光度组0.58 mm,单光组0.66 mm。
- 高附加光度 vs 单光组眼轴增长差异-0.23 mm(95% CI,-0.30 to -0.17);高附加光度 vs 中附加光度组-0.16 mm(95% CI,-0.23 to -0.09);中附加光度 vs 单光组-0.07 mm(95% CI,-0.14 to -0.01)。
- 4个次要终点中3个组间差异无统计学意义。
临床怎么用
- 对于7-11岁近视儿童,高附加光度(+2.50 D)多焦软镜可作为减缓近视进展的干预选择。
- 需权衡高附加光度与中附加光度及单光镜的差异,并结合个体情况决策。
局限性
- 研究仅纳入7-11岁、特定屈光度范围的儿童,外推需谨慎。
- 观察到的近视进展差异的临床重要性尚不明确,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Slowing myopia progression could decrease the risk of sight-threatening complications. OBJECTIVE: To determine whether soft multifocal contact lenses slow myopia progression in children, and whether high add power (+2.50 D) slows myopia progression more than medium (+1.50 D) add power lenses. DESIGN, SETTING, AND PARTICIPANTS: A double-masked randomized clinical trial that took place at 2 optometry schools located in Columbus, Ohio, and Houston, Texas. A total of 294 consecutive eligible children aged 7 to 11 years with -0.75 D to -5.00 D of spherical component myopia and less than 1.00 D astigmatism were enrolled between September 22, 2014, and June 20, 2016. Follow-up was completed June 24, 2019. INTERVENTIONS: Participants were randomly assigned to wear high add power (n = 98), medium add power (n = 98), or single-vision (n = 98) contact lenses. MAIN OUTCOMES AND MEASURES: The primary outcome was the 3-year change in cycloplegic spherical equivalent autorefraction, as measured by the mean of 10 autorefraction readings. There were 11 secondary end points, 4 of which were analyzed for this study, including 3-year eye growth. RESULTS: Among 294 randomized participants, 292 (99%) were included in the analyses (mean [SD] age, 10.3 [1.2] years; 177 [60.2%] were female; mean [SD] spherical equivalent refractive error, -2.39 [1.00] D). Adjusted 3-year myopia progression was -0.60 D for high add power, -0.89 D for medium add power, and -1.05 D for single-vision contact lenses. The difference in progression was 0.46 D (95% CI, 0.29-0.63) for high add power vs single vision, 0.30 D (95% CI, 0.13-0.47) for high add vs medium add power, and 0.16 D (95% CI, -0.01 to 0.33) for medium add power vs single vision. Of the 4 secondary end points, there were no statistically significant differences between the groups for 3 of the end points. Adjusted mean eye growth was 0.42 mm for high add power, 0.58 mm for medium add power, and 0.66 mm for single vision. The difference in eye growth was -0.23 mm (95% CI, -0.30 to -0.17) for high add power vs single vision, -0.16 mm (95% CI, -0.23 to -0.09) for high add vs medium add power, and -0.07 mm (95% CI, -0.14 to -0.01) for medium add power vs single vision. CONCLUSIONS AND RELEVANCE: Among children with myopia, treatment with high add power multifocal contact lenses significantly reduced the rate of myopia progression over 3 years compared with medium add power multifocal and single-vision contact lenses. However, further research is needed to understand the clinical importance of the observed differences. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02255474.
引用
- Walline JJ, Walker MK, Mutti DO, et al. Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial. JAMA. 2020. PMID: 32780139. doi:10.1001/jama.2020.10834
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。